Associations between demographic, disease related, and treatment pathway related variables and health related quality of life in primary care patients with coronary heart disease

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Kramer, Lena ^a   Hirsch, Oliver ^a   Schlößler, Kathrin ^a   Träger, Susanne ^a   Baum, Erika ^a   Donner Banzhoff, Norbert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Coronary artery disease; Critical pathways; Multilevel analyses; Quality of life

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EUROQOL EQ 5D; EXPERIMENTAL DESIGN; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENDER; GENERAL PRACTITIONER; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICINE; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CORONARY DISEASE; CRITICAL PATHWAYS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84863508972     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-78     Document Type: Article

References (58)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-1757. 10.1016/S0140-6736(06)68770-9, 16731270.
2. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002, 88(2):119-124. 10.1136/heart.88.2.119, 1767229, 12117828.
3. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006, 27(1):107-113.
4. Lange C, Ziese T. Daten und Fakten: Ergebnisse der Studie "Gesundheit in Deutschland aktuell 2009" 2010, Robert Koch Institut, Berlin.
5. Hall JA, Horgan TG, Stein TS, Roter DL. Liking in the physician-patient relationship. Patient Educ Couns 2002, 48(1):69-77. 10.1016/S0738-3991(02)00071-X, 12220752.
6. Hirsch O, Keller H, Albohn-Kuhne C, Krones T, Donner-Banzhoff N. Satisfaction of patients and primary care physicians with shared decision making. Eval Health Prof 2010, 33(3):321-342. 10.1177/0163278710376662, 20801975.
7. Stauber S, Schmid JP, Saner H, Znoj H, Saner G, Grolimund J, Von Känel R. Health-Related Quality of Life is Associated with Positive Affect in Patients with Coronary Heart Disease Entering Cardiac Rehabilitation. J Clin Psychol Med Settings 2012, . published online May 13.
8. Fortin M, Dubois M, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: A closer look. Health Qual Life Outcomes 2007, 5:52. 10.1186/1477-7525-5-52, 2042974, 17683600.
9. Mommersteeg P, Denollet J, Spertus J, Pedersen S. Health status as a risk factor in cardiovascular disease: A systematic review of current evidence. Am Heart J 2009, 157:208-218. 10.1016/j.ahj.2008.09.020, 19185627.
10. Radoschewski M. Gesundheitsbezogene Lebensqualität - Konzepte und Maße. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2000, 43:165-189.
11. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33(5):337-343. 10.3109/07853890109002087, 11491192.
12. EuroQolGroup EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQolGroup.
13. Xu R, Insinga RP, Golden W, Hu XH. EuroQol (EQ-5D) health utility scores for patients with migraine. Qual Life Res 2010, 20(4):601-608.
14. Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, Burstrom K. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res 2011, 20(3):309-320. 10.1007/s11136-010-9762-x, 3052443, 21042861.
15. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010, 8:13. 10.1186/1477-7525-8-13, 2824714, 20109189.
16. Goldsmith KA, Dyer MT, Schofield PM, Buxton MJ, Sharples LD. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health Qual Life Outcomes 2009, 7:96. 10.1186/1477-7525-7-96, 2789057, 19941657.
17. Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA. Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circ Cardiovasc Qual Outcomes 2008, 1(2):123-130. 10.1161/CIRCOUTCOMES.108.793448, 20031799.
18. Reibling N. Healthcare systems in Europe: towards an incorporation of patient access. J Eur Soc Pol 2010, 20:5-18.
19. Kinsman L, Rotter T, James E, Snow P, Willis J. What is a clinical pathway? Development of a definition to inform the debate. BMC Med 2010, 8:31. 10.1186/1741-7015-8-31, 2893088, 20507550.
20. de Stampa M, Vedel I, Mauriat C, Bagaragaza E, Routelous C, Bergman H, Lapointe L, Cassou B, Ankri J, Henrard JC. Diagnostic study, design and implementation of an integrated model of care in France: a bottom-up process with continuous leadership. Int J Integr Care 2010, 10:e034. 2834925, 20216954.
21. Vanhaecht K, Bollman M, Bower K, Gallagher C, Gardini A. Prevalence and use of clinical pathways in 23 countries - an international survey by the European Pathway Association. J Integr Care Pathw 2006, 10:28-34.
22. Ovretveit J. The future for care pathways. J Integr Care Pathw 2010, 14:76-78.
23. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008, 371(9629):1999-2012. 10.1016/S0140-6736(08)60868-5, 18555911.
24. Lelgemann M, Ollenschlager G. [Evidence based guidelines and clinical pathways: complementation or contradiction?]. Internist (Berl) 2006, 47(7):690. 692-697.
25. Silagy C, Weller D, Lapsely H, Middleton P, Shelby-James T, Fazekas B. The effectivenes of local adaptation of nationally produced clinical practice guidelines. Fam Pract 2002, 19(3):223-230. 10.1093/fampra/19.3.223, 11978710.
26. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655. 10.1136/bmj.a1655, 2769032, 18824488.
27. Bergert F, Braun M, Conrad D, Ehrenthal K, Feßler J, Gross J, Gundermann K, Hesse H, Hüttner U, Kluthe B, et al. Hausärztliche Leitlinie Stabile Angina pectoris und KHK 2006, Leitliniengruppe Hessen, Köln.
28. Nationale Versorgungsleitlinie Chronische KHK 2007, Deutscher Ärzte-Verlag, Köln.
29. Kramer L, Schlössler K, Träger S, Donner-Banzhoff N. Qualitative evaluation of a local coronary heart disease treatment pathway: practical implications and theoretical framework. BMC Fam Pract 2012, 13:36. 10.1186/1471-2296-13-36, 22584032.
30. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366(9493):1267-1278.
31. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008, 52(22):1769-1781. 10.1016/j.jacc.2008.08.039, 19022156.
32. O'Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med 2008, 121(1):24-33. 10.1016/j.amjmed.2007.06.033, 18187070.
33. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011, 19(1):CD004816.
34. Bhatt DL. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Am J Cardiol 2009, 103(3 Suppl):11A-19A.
35. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003, 163(17):2006-2010. 10.1001/archinte.163.17.2006, 14504112.
36. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, Guyatt GH, Mark DB, Harrington RA. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl):776S-814S. 10.1378/chest.08-0685, 18574278.
37. Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl):199S-233S. 10.1378/chest.08-0672, 18574266.
38. Myers C, Wilks D. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res 1999, 8(1-2):9-16.
39. Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, Scott-Lennox J, Feinberg J. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002, 11(3):273-282. 10.1023/A:1015240103565, 12074264.
40. EQ-5D Value Sets: Inventory, Comparative Review and User Guide 2007, Springer, Dordrech, Szende A, Oppe M, Devlin N.
41. Greiner W, Claes C. Der EQ-5D der EuroQol-Gruppe. Gesundheitsökonomische Evaluationen 2008, 403-414. Springer, Berlin, Schöffski O, Graf v.d. Schulenburg J-M.
42. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 2003, 4(3):222-231. 10.1007/s10198-003-0182-5, 15609189.
43. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004, 57(8):785-794. 10.1016/j.jclinepi.2003.12.013, 15485730.
44. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951, 38(1-2):141-149.
45. Ellis PD. The essential guide to effect sizes. Statistical power, meta-analysis, and the interpretation of research results 2010, Cambridge University Press, Cambridge.
46. Grissom RJ, Kim JJ. Effect sizes for research.A broad practical approach 2005, Lawrence Erlbaum Associates, Mahwah.
47. Heck RH, Thomas SL, Tabata LN. Multilevel and longitudinal modeling with IBM SPSS 2010, Routledge, New York.
48. Twisk JWR. Applied multilevel analysis. A practical guide 2006, Cambridge University Press, Cambridge.
49. National Research C. The Prevention and Treatment of Missing Data in Clinical Trials 2010, The National Academies Press, Washington D.C.
50. Kenward MG, Molenberghs G. Last observation carried forward: a crystal ball?. J Biopharm Stat 2009, 19(5):872-888. 10.1080/10543400903105406, 20183449.
51. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004, 10(2):307-312. 10.1111/j..2002.384.doc.x, 15189396.
52. Leslie SJ, Rysdale J, Lee AJ, Eteiba H, Starkey IR, Pell J, Denvir MA. Unemployment and deprivation are associated with a poorer outcome following percutaneous coronary angioplasty. Int J Cardiol 2007, 122(2):168-169. 10.1016/j.ijcard.2006.11.052, 17234282.
53. Kikuchi H, Mifune N, Niino M, Ohbu S, Kira J, Kohriyama T, Ota K, Tanaka M, Ochi H, Nakane S, et al. Impact and characteristics of quality of life in Japanese patients with multiple sclerosis. Qual Life Res 2011, 20(1):119-131. 10.1007/s11136-010-9725-2, 20700657.
54. Lund RS, Karlsen TI, Hofso D, Fredheim JM, Roislien J, Sandbu R, Hjelmesaeth J. Employment Is Associated with the Health-Related Quality of Life of Morbidly Obese Persons. Obes Surg 2010, 21(11):1704-1709.
55. Duenas M, Ramirez C, Arana R, Failde I. Gender differences and determinants of health related quality of life in coronary patients: a follow-up study. BMC Cardiovasc Disord 2011, 11:24. 10.1186/1471-2261-11-24, 3125287, 21619566.
56. van Jaarsveld CH, Sanderman R, Ranchor AV, Ormel J, van Veldhuisen DJ, Kempen GI. Gender-specific changes in quality of life following cardiovascular disease: a prospective study. J Clin Epidemiol 2002, 55(11):1105-1112. 10.1016/S0895-4356(02)00506-1, 12507674.
57. Skodova Z, Nagyova I, van Dijk JP, Sudzinova A, Vargova H, Studencan M, Reijneveld SA. Socioeconomic differences in psychosocial factors contributing to coronary heart disease: a review. J Clin Psychol Med Settings 2008, 15(3):204-213. 10.1007/s10880-008-9117-8, 19104965.
58. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342(8883):1317-1322. 10.1016/0140-6736(93)92244-N, 7901634.